Donga Pharmaceutical Launches "Noscadine Gel" for Acne Extraction Wound and Infection Care

Prevents Secondary Infections with Antibiotic Ingredients

Donga Pharmaceutical announced on January 15 that it has launched a new product, "Noscadine Gel," designed to help treat wounds and secondary infections that occur after acne extraction.

Advertising image of Donga Pharmaceutical's acne extrusion secondary infection treatment product, "Noscadine Gel." Donga Pharmaceutical

The main ingredient in Noscadine Gel is fusidic acid hydrate (2%), an antibiotic. Fusidic acid hydrate is effective against Staphylococcus aureus and Streptococcus, which are major causes of skin infections, as well as acne bacteria. It helps prevent bacterial infections at the extraction site.

The formula has also been enhanced with ingredients that promote skin regeneration and soothing. It contains dexpanthenol, a vitamin component, as well as moisturizing ingredients such as hyaluronic acid and aloe vera gel, which quickly calm irritated skin. The product is developed as a refreshing gel type that is low in oiliness and non-sticky. A hygienic tube container has been adopted to improve user convenience.

A representative from Donga Pharmaceutical stated, "We believe this product will be helpful for consumers who are unsure how to care for their skin after acne extraction."